Further confirmation of this study was obtained from the research of Sinowatz, F. et al. [183], in which bFGF expression was found in stromal cells in both benign prostatic hyperplasia and prostate cancer [184] from the studies of immunohistochemistry and molecular biology. This evidence concerns the gene FGF2 and prostate carcinoma.